A polymorphism in the CTGF promoter region associated with systemic sclerosis.
about
Functions and mechanisms of action of CCN matricellular proteinsCurrent perspectives on the immunopathogenesis of systemic sclerosisEyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilaritiesGenetics, Epigenetics, and Genomics of Systemic SclerosisTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsProteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors.Impact of IL-10 (-1082) promoter-single nucleotide polymorphism on the outcome of hepatitis C virus genotype 4 infectionHLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.Systemic sclerosis-associated pulmonary arterial hypertensionCCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling networkMyocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.Genetics of scleroderma: implications for personalized medicine?Connective tissue growth factor (CTGF) expression modulates response to high glucose.Investigating the association between polymorphisms in connective tissue growth factor and susceptibility to colon carcinoma.Identification of radiation-induced aberrant hypomethylation in colon cancer.Topically applied connective tissue growth factor/CCN2 improves diabetic preclinical cutaneous wound healing: potential role for CTGF in human diabetic foot ulcer healing.Fibrotic response in fibroblasts from congenital disorders of glycosylation.Lack of CTGF*-945C/G Dimorphism in Thai Patients with Systemic Sclerosis.Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil.The CTGF gene -945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetesGenetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis.Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian PopulationFunctional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based ChemotherapyA large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?Genetic architecture of human fibrotic diseases: disease risk and disease progression.Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with schistosomes.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.The myofibroblast matrix: implications for tissue repair and fibrosis.Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis.Autoimmune mechanisms of scleroderma and a role of oxidative stress.Deciphering the genetic background of systemic sclerosis.Fibroblast abnormalities in the pathogenesis of systemic sclerosis.Targeted therapies for systemic sclerosis.The effect of TGF-β1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature.Update on etiopathogenesis of systemic sclerosis.Molecular and cellular basis of scleroderma.Cytokines in the immunopathology of systemic sclerosis.
P2860
Q24642303-6CFD7624-34A9-46AF-84E3-35F606DCB59DQ26741264-1709E79F-A267-4857-A2CA-F7F9053DB5B7Q26782080-DCBFE899-9117-46E9-B9C0-9D4A4C507A74Q26799577-64001142-DC6D-4D3E-9C86-B669E70ACDDFQ28254386-7BED24BB-5BF4-44C3-8AB5-CFC4564EEACEQ33357303-06D1D636-9909-45AA-A52C-F6A234F77600Q33522307-53170F47-0496-41DC-9252-B2169086775FQ33603248-7DC1FEBD-7404-4E0B-86AC-EF863B3A2B1FQ33690850-566E0BBA-B721-4F3F-B621-2A1533E385ADQ33950086-F1E8ECF0-928E-4872-8A8E-87FEB012760BQ33961583-1A57D582-43F6-4378-8FC8-017F24898FEBQ34533036-CED5358B-BCF7-4AE6-97E9-8249C7CDE473Q34545752-C51B9804-B266-43EA-9F14-84CACFE53451Q34946924-1423A7A6-0515-46A1-8977-C2CAF452044BQ35110806-A34D2172-9249-4292-9F41-DF95BE85BC07Q35127773-F30BE2BA-6FC7-4BC2-973A-B0202227FDE1Q35144096-AEBD5BED-EDA7-480D-B4EC-B2E0F114D62FQ35216162-05E81CCC-1534-4368-A3A4-78DCD2E7551AQ35480267-3CF13EEC-011F-4C64-BA73-4830C02CFD93Q35649228-8571A76B-AD4F-4763-A224-6441CBA24578Q36024042-23572C7B-A3D9-466B-AF81-7D11F74C3FE2Q36226407-4C20A57D-A29A-45EB-8DAE-533D6638B442Q36685226-D2F75177-E57C-4403-A3AD-96FDF24F5D34Q36854651-ADC3675B-4389-4472-BC66-35E4CD9DF0F6Q36993563-15C6C186-8AB4-45A2-8445-4FBA26F10BF3Q37346330-3F75B78F-98B5-429E-89AF-C83C5F2D8902Q37373460-DE2D5A9C-46A4-40B0-87A8-2DD2E86817CDQ37400152-47888D1B-0296-4C5B-94AE-BE06DFCA3E50Q37402387-BFB6417B-A3A3-4AC3-8FCB-170BB1EB1927Q37638268-73B28AE0-56AC-4D81-8CF2-54128FA92DE3Q37733670-2D112834-BF3D-481C-9BFF-2CA964879217Q37898746-3DEB7811-0C52-4913-AE7C-990128977DC6Q37903252-7423E97D-6AF7-4E79-8059-5B9126E17BCEQ37905783-9D886AF3-13F0-49FA-AD23-6701B852382CQ37905795-877EE105-2EAA-45D1-8B71-532FD76E6EACQ38097276-3EF9DDC7-64D2-4B4B-950D-5D0DC407ED9AQ38122314-CAE7B187-963C-4484-A62E-D1B8C56A7CAAQ38183300-44D606A9-84FF-41FC-944D-6EB105BD202CQ38230276-E1BCA8EB-ACB8-4589-8851-DDA1BD9C37E1Q38543692-947A094A-4743-4F2C-A987-D7141E9BF159
P2860
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@ast
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@en
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@nl
type
label
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@ast
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@en
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@nl
prefLabel
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@ast
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@en
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
@nl
P2093
P356
P1476
A polymorphism in the CTGF promoter region associated with systemic sclerosis
@en
P2093
Alan M Holmes
Carmen Fonseca
Carol M Black
Christopher P Denton
David J Abraham
Gisela E Lindahl
Kenneth I Welsh
Markella Ponticos
Neil McHugh
Panagiotis Pantelidis
P304
P356
10.1056/NEJMOA067655
P407
P577
2007-09-01T00:00:00Z